NCT03823612

Brief Summary

to remineralize the white spot caries lesions after orthodontic treatment , the investigator will use two different materials ( Clinpro tooth creme versus Gc tooth mousse) and will compare between their effects in remineralization of white spot caries lesions.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
34

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Mar 2019

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 28, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 30, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

March 1, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2019

Completed
Last Updated

January 30, 2019

Status Verified

January 1, 2019

Enrollment Period

6 months

First QC Date

January 28, 2019

Last Update Submit

January 29, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • esthetic assessment

    Spectrophotometer ( L, a, b) will be used to measure the change in the shade of the white spot lesions during the study

    baseline, after 1 month , 3 months and 6 months of the application

Secondary Outcomes (1)

  • patient compliance

    6 months

Study Arms (2)

GC tooth mousse

EXPERIMENTAL

Drug: GC tooth mousse it contains complex of Casein Phosphopeptide,Amorphous Calcium Phosphate ( CPP-ACP ) other name: Tooth Mousse (Bio-available calcium and phosphate, without fluoride)

Drug: GC tooth mousse

clinpro tooth creme

ACTIVE COMPARATOR

it contains 0.21% Sodium Fluoride, Anti-Cavity Paste is an advanced formula containing an innovative tri-calcium phosphate ingredient other name:0.21% w/w Sodium Fluoride Anti-Cavity Paste with Tri-Calcium Phosphate

Drug: Clinpro Tooth Creme

Interventions

The participant will be instructed to Place a pea-sized amount of Clinpro Tooth Crème on a soft bristled toothbrush and brush teeth for at least two minutes then after brushing the patient will rinse out his mouth with water and spit out. It will be used twice daily at first in the morning and before sleep.

Also known as: Anti-Cavity Paste with Tri-Calcium Phosphate
clinpro tooth creme

The participant will be instructed to squeeze a small amount of GC Tooth Mousse out onto a clean finger. A cotton tip, swab or custom tray are suitable application methods as it will Applied directly onto his tooth surfaces and leave undisturbed for three minutes then he will be instructed to Spread any residual crème around the mouth with his tongue and hold for a further one to two minutes then the participant will expectorate thoroughly and if possible he should avoid rinsing. Any GC Tooth Mousse remaining in the mouth can be left to gradually dissipate. The participant will be instructed to avoid eating or drinking for 30 minutes following application.

GC tooth mousse

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients should have at least one white spot caries lesion
  • age from 18 to 40 years
  • no gender restriction

You may not qualify if:

  • Patients with a compromised medical history.
  • Severe or active periodontal disease
  • Patients with developmental hypo-calcified lesions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Donia Mahmoud Abd El Moaty

Cairo, Egypt

RECRUITING

MeSH Terms

Interventions

casein phosphopeptide-amorphous calcium phosphate nanocomplex

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principle investigator in cairo university

Study Record Dates

First Submitted

January 28, 2019

First Posted

January 30, 2019

Study Start

March 1, 2019

Primary Completion

September 1, 2019

Study Completion

October 1, 2019

Last Updated

January 30, 2019

Record last verified: 2019-01

Locations